Comments: NJ S919 | 2020-2021 | Regular Session
Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2020-01-27 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S919 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2020-01-27 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S919 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2020 New Jersey S919 at this time. |